Michael Farley — Executive VP of Corporate Development, GBS Global Biopharma, Inc.

Michael has 30 years of experience in the biomedical field as corporate advisor, manager and investor. In the 1990s he managed inward investments for the Canadian Department of Foreign Affairs, including the Connaught Biosciences-Pasteur Merieux merger, the largest Pharma transaction in Canada at the time. In 2001, Michael founded a boutique advisory firm (Canada, Switzerland) offering business services to biotech, med-tech, specialty pharma and nutraceutical companies. Clients raised $150 M+ from investors in EU, NA and Asia. In 2006 he syndicated a $30 M financing from NA and EU investors for an ECS development company running trials for a CB1 inverse agonist API. Michael is active in the food and beverage industry as Founder/President of a natural food importing company (exited 2002) and is currently Director of a wine production and distribution company in California. He holds a PhD in the Philosophy of Science from the Université de Montréal (1986) and is fluent in several languages.